vTv Therapeutics Inc expected to post a loss of 7  cents a share - Earnings Preview

vTv Therapeutics

19/02/2022 24:42

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
22 (estimated). 
    * The High Point North Carolina-based  company is expected
to
report  a 84.4% decrease in revenue to $1 million from $6.4
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for vTv Therapeutics
Inc is
for a loss of 7 cents per share. For the same quarter last year,
the company reported earnings of 2 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $6.75​, about 87.4% above​ its last closing price
of $0.85. ​​​

This summary was machine generated February 19 at 00:42 GMT. 
All figures in US dollars  unless otherwise stated